Eurofins Viracor has developed and validated a first-of-its-kind next generation sequencing assay. NeXGen™ hybrid-capture NGS emerges as a superior choice in infectious disease identification. Hybrid-capture NGS is a powerful technique that combines the specificity of target capture with the high-throughput capabilities of NGS offering advantages such as:
NeXGen hybrid-capture NGS offers a powerful and comprehensive approach to infectious disease testing, providing clinicians with valuable insights on prominent or “low load” clinically relevant microorganisms allowing for a more accurate diagnosis and appropriate treatment decisions.
hybrid-capture next generation sequencing
Click for a detailed Organism Dataset PDF list
Absidia (26)
Actinomucor (1)
Actinomyces (40)
Aggregatibacter (1)
Alternaria (3)
Apiotrichum (1)
Apophysomyces (3)
Aspergillus (42)
Aureobasidium (4)
Basidiobolus (2)
Blastomyces (3)
Candida (25)
Chaetomium (1)
Chrysosporium (1)
Cladophialophora (5)
Cladosporium (1)
Clavispora (1)
Coccidioides (2)
Cokeromyces (1)
Conidiobolus (1)
Coniosporium (1)
Cryptococcus (2)
Cryptococcus gattii VGI (1)
Cryptococcus gattii VGII (1)
Cryptococcus gattii VGIII (1)
Cunninghamella (11)
Curvularia (2)
Cutaneotrichosporon (1)
Cyberlindnera (2)
Cyphellophora (1)
Debaryomyces (2)
Diutina (1)
Emergomyces (5)
Emmonsia (1)
Enterocytozoon (1)
Exophiala (7)
Filobasidium (1)
Fonsecaea (5)
Fusarium (25)
Geotrichum (1)
Histoplasma (1)
Hyphopichia (1)
Kluyveromyces (2)
Leptosphaeria (1)
Lichtheimia (2)
Lodderomyces (1)
Lomentospora (1)
Madurella (1)
Malassezia (13)
Memnoniella (1)
Metarhizium (7)
Metschnikowia (2)
Meyerozyma (2)
Microsporum (1)
Mortierella (1)
Mucor (5)
Mycobacterium (115)
Mycobacterium abscessus (4)
Mycobacterium avium (1)
Mycobacterium avium subsp. paratuberculosis (1)
Mycobacterium avium subsp. silvaticum (1)
Mycobacterium intracellulare (1)
Mycobacterium intracellulare subsp. chimaera (1)
Mycobacterium intracellulare subsp. (1) yongonense
Mycobacterium tuberculosis Complex (5)
Mycobacteroides abscessus (1)
Mycobacteroides abscessus
subsp. bolletii (1)
Mycobacteroides abscessus subsp. (1) massiliense
Mycobacteroides (1)
Mycolicibacter (2)
Mycolicibacterium (18)
Mycolicibacterium fortuitum (3)
Nakaseomyces (2)
Nannizzia (1)
Nigrograna (1)
Nocardia (98)
Nocardiopsis (1)
Paecilomyces (1)
Paracoccidioides (2)
Pascua (1)
Penicillium (23)
Phaeoacremonium (1)
Phaeotremella (2)
Phialophora (1)
Pichia (1)
Pneumocystis (3)
Podila (1)
Purpureocillium (1)
Rasamsonia (13)
Rhinocladiella (1)
Rhizomucor (2)
Rhizopus (5)
Rhodotorula (3)
Rhytidhysteron (1)
Saccharomyces (1)
Saksenaea (2)
Samsoniella (1)
Scedosporium (4)
Schaalia (3)
Schizophyllum (1)
Sporothrix (4)
Stachybotrys (2)
Starmerella (2)
Suhomyces (1)
Syncephalastrum (2)
Talaromyces (11)
Thermoascus (1)
Thermothelomyces (1)
Trichoderma (9)
Trichophyton (6)
Trichosporon (2)
Ustilago (5)
Verruconis (7)
Wallemia (2)
Wickerhamiella (2)
Wickerhamomyces (2)
Yamadazyma (1)
Yarrowia (1)
BROCHURE:
It offers advantages such as:
Read More...
Hybrid-Capture NGS for Detecting Fungal and Acid-Fast Bacteria
Next Generation Sequencing (NGS) testing has gained significant importance in the medical clinical laboratory in the United States over the past decade. In recent years, the field of molecular diagnostics has witnessed significant advancements, particularly in the detection of infectious diseases. One such breakthrough is the application of hybrid-capture next-generation sequencing (NGS) technology.
33356 - NeXGen™ Fungal / AFB Next Generation Sequencing (NGS) Assay